長谷　敬太郎　業績集

英文業績（2012年から現在まで）

IF (impact factor)：　2022年ISI Journal Citation Reportsより

1. Usui Y, Kinouchi R, Nakano S, Iwahashi C, Hase K, Nagata K, Sugimoto M, Hasegawa E, Tsubota K, Kusuhara S, Akiyama M, Kashiwagi K, Takeda A, Kaburaki T, Goto H, Sonoda K. Protocol for Japan-acute retinal necrosis (J-ARN) registry: A combined prospective and retrospective cohort study. PLoS One. 2025; 20: e0323822
2. Pfeifer CW, Walsh JT, Santeford A, Lin JB, Beatty WL, Terao R, Liu YA, Hase K, Ruzycki PA, Apte RS. Dysregulated CD200-CD200R signaling in early diabetes modulates microglia-mediated retinopathy. Proc Natl Acad Sci U S A. 2023; 120: 45
3. Shinagawa M, Namba K, Mizuuchi K, Iwata D, Hase K, Suzuki K, Hirooka K, Kitaichi N, Hiraoka M, Ishida S. The Steroid-Sparing Effect of Adalimumab in the Treatment for the Recurrent Phase of Vogt–Koyanagi–Harada Disease. Ocul Immunol Inflamm. 2023; 31: 501-505
4. Suzuki K, Iwata D, Namba K, Hase K, Hiraoka M, Murata M, Kitaichi N, Foxton R, Ishida S. Involvement of Angiopoietin 2 and vascular endothelial growth factor in uveitis. PLoS One. 2023; 18: e0294745
5. Takeuchi M, Usui Y, Namba K, Keino H, Takeuchi M, Takase H, Kamoi K, Hase K, Ito T, Nakai K, Maruyama K, Kobayashi E, Mashimo H, Sato T, Ohguro N, Hori J, Okada AA, Sonoda KH, Mizuki N, Goto H. Ten-year follow-up of infliximab treatment for uveitis in Behcet disease patients: A multicenter retrospective study. Front Med. 2023; 10: 1095423
6. Kase S, Namba K, Iwata D, Mizuuchi K, Suzuki K, Ito T, Hase K, Kitaichi N, Ishida S. Diagnostic accuracy of cell block preparations and clinical features affecting it in vitreoretinal lymphoma. J Clin Med. 2022; 11: 1391
7. Murata M, Noda K, Kase S, Hase K, Wu D, Ando R, Ishida S. Placental growth fator stabilizes VEGF receptor-2 protein in retinal pigment epithelial cells by downregulating glycogen synthase kinase 3 activity. J Biol Chem. 2022; 298: 102378
8. Suzuki K, Ishihara M, Namba K, Ohno S, Goto H, Takase H, Kawano S, Shibuya E, Hase K, Iwata D, Mizuuchi K, Kitaichi N, Mizuki N, Ishida S. Clinical features of ocular sarcoidosis: severe, refrectory, and prolonged inflammation. Jpn J Ophthalmol. 2022; 66: 447-454
9. Suzuki K, Namba K, Hase K, Mizuuchi K, Iwata D, Ito T, Kitaichi N, Takase H, Ishida S. A case of Epstein-Barr virus acute retinal necrosis successfully treated with foscarnet. Am J Ophthalmol Case Rep. 2022; 25: 101363
10. Suzuki K, Namba K, Kase S, Ogino Y, Hase K, Iwata D, Mizuuchi K, Hiraoka M, Kitaichi N, Ishida S. Clinical significance of serum and vitreous soluble interleukin-2 receptor in patients with intraocular lymphoma. BMC Ophthalmol. 2022; 22: 428
11. Yokoi K, Namba K, Iwata D, Mizuuchi K, Hase K, Suzuki K, Ando R, Hirooka K, Sekine N, Kitaichi N, Hiraoka M, Ishida S. Fundus autofluorescence imaging in acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol Case Rep. 2022; 28: 101732
12. Yoneda Y, Usui Y, Tanaka R, Hase K, Namba K, Kamoi K, Takase H, Takeuchi M, Matsumiya W, Kusuhara S, Takeda A, Yawata N, Yanai R, Hiyama T, Harada Y, Hashida N, Maruyama K, Nakai K, Taguchi R, Kaburaki T, Mizuki N, Goto H, Fujino Y, Takeuchi M. Factors associated with low prevalence of Fuchs’ uveitis syndrome in Japan. Front Med. 2022; 9: 999804
13. Hase K, Kase S, Kanda A, Shinmei Y, Noda K, Ishida S. Expression of vascular endothelial growth factor-C in the trabecular meshwork of patients with neovascular glaucoma and primary open-angle glaucoma. J Clin Med. 2021; 10: 2977
14. Hase K, Namba K, Wada H, Tsuji H, Maeda A, Murata T, Otsuka R, Iwata D, Kanda A, Noda K, Kitaichi N, Seino K, Ishida S. iPS-derived suppressor cells reduce Th1-mediated immune response to a retinal antigen. Curr Eye Res. 2021; 46: 1908-1916
15. Kase S, Namba K, Iwata D, Mizuuchi K, Ito T, Hase K, Suzuki K, Onozawa M, Kitaichi N, Ishida S. Clinical Features of Primary Vitreoretinal Lymphoma: A Single-center Study. Cancer Diagn Progn. 2021; 1: 69-75
16. Suzuki K, Namba K, Mizuuchi K, Iwata D, Ito T, Hase K, Kitaichi N, Ishida S. Development of cytomegalovirus retinitis after negative conversion of cytomegalovirus antigenemia due to systemic antiviral therapy. Graefes Arch Clin Exp Ophthalmol. 2021; 259: 971-978
17. Suzuki K, Namba K, Mizuuchi K, Iwata D, Ito T, Hase K, Kitaichi N, Ishida S. Validation of systemic parameters for the diagnosis of ocular sarcoidosis. Jpn J Ophthalmol. 2021; 65: 191-198
18. Ishizuka ET, Kanda A, Shinmei Y, Ohguchi T, Tagawa Y, Hase K, Yamamoto T, Noda K, Chin S, Ishida S. Receptor-Associated Prorenin System in the Trabecular Meshwork of Patients with Primary Open-Angle Glaucoma and Neovascular Glaucoma. J Clin Med. 2020; 9: 2336
19. Liu Y, Kitaichi N, Wu D, Hase K, Satoh M, Iwata D, Namba K, Kanda A, Noda K, Itai A, Iwabuchi K, Ishida S. Attenuation of experimental autoimmune uveoretinitis in mice by IKKβ inhibitor IMD-0354. Biochem Biophys Res Commun. 2020; 525: 589-594
20. Hase K, Kanda A, Noda K, Ishida S. Increased plasma galectin-1 correlates with advanced glycation end products and interleukin-1β in patients with proliferative diabetic retinopathy. Int J Ophthalmol. 2019; 12: 692-694
21. Hase K, Kanda A, Hirose I, Noda K, Ishida S. Systemic factors related to soluble (pro)renin receptor in plasma of patients with proliferative diabetic retinopathy. PLoS One. 2017; 12: e0189696
22. Hase K, Namba K, Saito W, Ohno S, Ishida S. A case of tuberculous endophthalmitis successfully treated with vitrectomy followed by antituberculous agents. J Ophthalmic Inflamm Infect. 2015; 5: 14
23. Hase K, Kase S, Noda M, Ohashi T, Shinkuma S, Ishida S. Ectopic cilia: A histopathologic study. Case Report Dermatol. 2012; 4: 37-40